Is the left atrial appendage more than a simple appendage?

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 2, 2009, Pages 234-242

  Hara, Hidehiko ^a,e   Virmani, Renu ^b   Holmes Jr , David R ^c   Buchbinder, Maurice ^d   Lesser, John R ^a   van Tassel, Robert A ^a   Mooney, Michael R ^a   Schwartz, Robert S ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b CVPATH INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d SCRIPPS CLINIC   (United States)

^e TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Atrial fibrillation; Left atrial appendage; Transcatheter occlusion

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; IRBESARTAN; PLACEBO; WARFARIN;

ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONGENITAL MALFORMATION; FEASIBILITY STUDY; HEART ATRIUM; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HISTOPATHOLOGY; HUMAN; THROMBOEMBOLISM; TRANSLUMINAL VALVULOPLASTY; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; EMBOLISM; FEMALE; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 70349501339     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21983     Document Type: Article

References (52)

1. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
2. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007;115:2689-2696.
3. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160:41-46.
4. Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007; 49:1490-1495.
5. Al-Saady NM, Obel OA, Camm AJ. Left atrial appendage: Structure, function, and role in thromboembolism. Heart 1999;82:547-555.
6. Moore KL. The Developing Human: Clinically Oriented Embryology. 6th ed. Philadelphia PA: W.B. Saunders; 1998.
7. Sharma S, Devine W, Anderson RH, Zuberbuhler JR. The determination of atrial arrangement by examination of appendage morphology in 1842 heart specimens. Br Heart J 1988;60:227-231.
8. Ernst G, Stöllberger C, Abzieher F, Veit-Dirscherl W, Bonner E, Bibus B, Schneider B, Slany J. Morphology of the left atrial appendage. Anat Rec 1995;242:553-561.
9. Veinot JP, Harrity PJ, Gentile F, Khandheria BK, Bailey KR, Eickholt JT, Seward JB, Tajik AJ, Edwards WD. Anatomy of the normal left atrial appendage: A quantitative study of agerelated changes in 500 autopsy hearts: Implications for echocardiographic examination. Circulation 1997;96:3112-3115.
10. Su P, McCarthy KP, Ho SY. Occluding the left atrial appendage: Anatomical considerations. Heart 2008;94:1166-1170.
11. Stollberger C, Schneider B, Finsterer J. Elimination of the left atrial appendage to prevent stroke or embolism?. Anatomic, physiologic, and pathophysiologic considerations. Chest 2003; 124:2356-2362.
12. Raman R, Al-Ali SY, Poole CA, Dawson BV, Carman JB, Calder L. Isomerism of the right atrial appendages: clinical, anatomical, and microscopic study of a long-surviving case with asplenia and ciliary abnormalities. Clin Anat 2003;16:269-276.
13. Friedberg MK, Ursell PC, Silverman NH. Isomerism of the left atrial appendage associated with ventricular noncompaction. Am J Cardiol 2005;96:985-990.
14. Lai WW, Ravishankar C, Gross RP, Kamenir SA, Lopez L, Nguyen KH, Griepp RB, Parness IA. Juxtaposition of the atrial appendages: a clinical series of 22 patients. Pediatr Cardiol 2001;22:121-127.
15. Shirani J, Alaeddini J. Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: Implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography. Cardiovasc Pathol 2000;9:95-101.
16. Spigel J, Key C. Thrombosis and infarction of the left atrial appendage in an infant: A case report. Am J Cardiovasc Pathol 1988;2:87-90.
17. King TD, Gnarra D, Stanford W, Cline RE. Endocardial fibroelastosis and aneurysmal dilatation of the left atrial appendage. Am J Dis Child 1973;125:721-723.
18. Tsukube T, Ataka K, Taniguchi T, Yokoyama M, Hanioka K. Papillary fibroelastoma of the left atrial appendage: Echocardiographic findings. Ann Thorac Surg 2000;70:1416-1417.
19. de Bold AJ, Bruneau BG, Kuroski de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 1996;31:7-18.
20. Haanwinckel MA, Elias LK, Favaretto AL, Gutkowska J, McCann SM, Antunes-Rodrigues J. Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci USA 1995;92:7902-7906.
21. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: Enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 2004;109:2872-2877.
22. Chapeau C, Gutkowska J, Schiller PW, Milne RW, Thibault G, Garcia R, Genest J, Cantin M. Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species. J Histochem Cytochem 1985;33:541-550.
23. Yoshihara F, Nishikimi T, Kosakai Y, Isobe F, Matsuoka H, Takishita S, Kawashima Y, Saito Y, Matsuo H, Kangawa K. Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure. J Thorac Cardiovasc Surg 1998;116:213-219.
24. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000;6:92-96.
25. Igarashi Y, Kashimura K, Makiyama Y, Sato T, Ojima K, Aizawa Y. Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state. Jpn Circ J 2001;65:788-792.
26. Henry JP, Gauer OH, Reeves JL. Evidence of the atrial location of receptors influencing urine flow. Circ Res 1956;4:85-90.
27. Tabata T, Oki T, Yamada H, Abe M, Onose Y, Thomas JD. Relationship between left atrial appendage function and plasma concentration of atrial natriuretic peptide. Eur J Echocardiogr 2000;1:130-137.
28. Cohen AJ, Tamir A, Yanai O, Houri S, Schachner A. Inverted left atrial appendage presenting as a left atrial mass after cardiac surgery. Ann Thorac Surg 1999;67:1489-1491.
29. Turhan S, Kilickap M, Candemir B, Berkalp B, Eren NT, Akgun G. Three unusual myxomas originating from the left atrial appendage: A case report. J Am Soc Echocardiogr 2005;18:694.
30. Tanoue Y, Kado H, Shiokawa Y, Sagawa K. Left atrial appendage aneurysm in a child. Ann Thorac Surg 2004;77:721-723.
31. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-759.
32. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med 1992;116:6-12.
33. Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC. Ischemic stroke in patients with atrial fibrillation: Effect of aspirin according to stroke mechanism.Stroke Prevention in Atrial Fibrillation Investigators. Neurology 1993;43:32-36.
34. Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, McBride R, Nasco E, Sherman DG, Talbert RL, Marler JR. Stroke Prevention in Atrial Fibrillation Investigators. Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann Intern Med 2003;138:831-838.
35. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, Moomaw CJ, Haverbusch M, Broderick JP. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 2007;68:116-121.
36. Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:287S-310S.
37. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
38. ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial. Lancet 2006;367:1903-1912.
39. Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, De Caterina R, Flaker G, Yusuf S, Connolly SJ. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke 2008;39:1482-1486.
40. Olsson SB. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): Randomised controlled trial. Lancet 2003;362:1691-1698.
41. Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, Halperin JL, Horrow J, Olsson SB, Petersen P, Vahanian A,SPORTIF Executive Steering Committee for the SPORTIF V Investigators. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: A randomized trial. JAMA 2005;293:690-698.
42. Ohyama H, Hosomi N, Takahashi T, Mizushige K, Osaka K, Kohno M, Koziol JA. Comparison of magnetic resonance imaging and transesophageal echocardiography in detection of thrombus in the left atrial appendage. Stroke 2003;34:2436-2439.
43. Hara H, Holmes DR Jr, Van Tassel RA, Schwartz RS. The left atrial appendage. Anatomy, physiology, and therapeutic percutaneous closure. In: Eric J, Topol M, editors. Textbook of Interventional Cardiology, 5th ed. Philadelphia: Saunders; 2007. pp 863-877.
44. Reed PS, Almany S. Left atrial appendage septae not visualized with transesophageal echocardiography. Catheter Cardiovasc Interv 2006;68:542-543.
45. Katz ES, Tsiamtsiouris T, Applebaum RM, Schwartzbard A, Tunick PA, Kronzon I. Surgical left atrial appendage ligation is frequently incomplete: A transesophageal echocardiographic study. J Am Coll Cardiol 2000;36:468-471.
46. Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, Cybulsky I, Abouzahr L, Sawchuck C, Carroll S, Morillo C, Kleine P, Chu V, Lonn E, Connolly SJ. Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005;150:288-293.
47. Blackshear JL, Johnson WD, Odell JA, Baker VS, Howard M, Pearce L, Stone C, Packer DL, Schaff HV. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 2003;42:1249-1252.
48. Kanderian AS, Gillinov AM, Pettersson GB, Blackstone E, Klein AL. Success of surgical left atrial appendage closure: Assessment by transesophageal echocardiography. J Am Coll Cardiol 2008;52:924-929.
49. Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della Bella P, Nakai T, Reisman M, DiMario C, Block P, Kramer P, Fleschenberg D, Krumsdorf U, Scherer D. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: Early clinical experience. Circulation 2002;105:1887-1889.
50. Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, Ruiz CE, Hijazi ZM. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003; 60:417-422.
51. Hara H, Matthews RV, Virmani R, Schwartz RS. Percutaneous left atrial appendage obliteration. J Am Coll Cardiol Img 2008; 1:92-93.
52. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870.